Company Medicure Inc Toronto S.E.
Equities
MPH
CA58469E4085
Biotechnology & Medical Research
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Marketing and Distribution of Commercial Products
55.9
%
| 15 | 66.3 % | 12 | 55.9 % | -20.70% |
Retail and Mail Order Pharmacy
44.1
%
| 8 | 33.7 % | 10 | 44.1 % | +23.04% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 23 | 100.0 % | 22 | 100.0 % | -5.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 76 | 97-09-14 |
Haaris Uddin
DFI | Director of Finance/CFO | - | 22-05-31 |
Neil Owens
PSD | President | - | 13-12-31 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arnold Naimark
BRD | Director/Board Member | 90 | 00-02-27 |
Peter Quick
BRD | Director/Board Member | 68 | 05-11-28 |
Albert Friesen
CEO | Chief Executive Officer | 76 | 97-09-14 |
Brent Fawkes
BRD | Director/Board Member | 54 | 13-01-21 |
James Kinley
BRD | Director/Board Member | 45 | 22-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,436,313 | 7,607,266 ( 72.89 %) | 0 | 72.89 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |